Relationship Between "FODMAPs" and "GVHD"

NCT04660487 · tracked via the Priya Life Science China tracker

Sponsor

The First Affiliated Hospital of Soochow University

Phase

Observational

Started

2020-12-01

Last updated

2025-12-31

Condition(s) studied

Graft Versus Host Disease

Study summary

With the stem cell transplanting increasing, patients which effected with "GVHD" were also increased. To evaluation the relationship between "FODMAPs" and "GVHD", Bone marrow transplant patients were recruited.

Eligibility

Sex

ALL

Min age

18 Years

Max age

60 Years

Healthy volunteers

Inclusion Criteria: 1. Clinical diagnosis of "AML","ALL","MDS" or "MM" Disease; 2. Must be treated with bone marrow transplantation; 3. The transplanted bone marrow was successfully planted Exclusion Criteria: 1. Gastrointestinal diseases； 2. Age\>60; or Age\<10； 3. Probiotics or prebiotics were taken before enrollment

Primary outcome measure(s)

Occurrence of GVHD — 90 days
The occurrence time and degree of GVHD

Trial sites (1)

Facility	City	Region	Status
中国	Suzhou	Jiangsu	Recruiting

More The First Affiliated Hospital of Soochow University trials in China

A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML Recruiting

Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML Starting soon

A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia Starting soon

N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy Active, not recruiting

CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia Active, not recruiting

Other trials for the same condition

Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD Enrolling by invitation

CINC424A2X01B Rollover Protocol Active, not recruiting

Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation Recruiting

Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04660487 on ClinicalTrials.gov ↗ ← All trials in China